Future studies should explore the cargos carried by EVs-CD10+CD19+, how it affects the leukemic microenvironment and, ultimately, its potential as a combined diagnostic and prognostic biomarker for B-ALL. Here, CD19 is linked to acute lymphoblastic leukemia.